doi: 10.1016/S2213-8587(22)00387-4 Summary Keywords type 2 diabetes, children, SGLT2 inhibitors, empagliflozin, hyperglycemia Citation Castorani V, Chiarle E, Savastio S, Pozzi E, Partenope C, Pignatiello C, Dimarakis S, Demichelis M, Medina F and Rabbone I (2025) Established and emerging use of sodium-glucose cotransporter-2 inhibitors in pediatric population with type 2 diabetes: a case report and literature review
IV administration provides immediate systemic circulation versus gradual absorption with oral supplements
Before sticking the needle into the vial, always clean the top of the vial with a NEW alcohol wipe
Many of the health conditions MTHFR may or may not be associated with are unlikely to be caused by a single gene or genetic variants within that gene
Unlike in the first case, her PCP had an established relationship with her, was aware of her ED, and had prescribed Wegovy with a full understanding of her co-occurring conditions